Description
DR LALCHANDANI LABS LIMITED announces 1:1 rights issue at par value of Rs.10 per share with record date on January 27, 2026.
Summary
BSE has notified that DR LALCHANDANI LABS LIMITED (Scrip Code: 541299) has fixed the record date for its rights issue of equity shares. The company will issue 1 equity share of Rs.10 each for every 1 equity share held, at par value. Trading in the company’s shares will commence on ex-rights basis from January 27, 2026.
Key Points
- Rights ratio: 1:1 (One new equity share for every one equity share held)
- Issue price: Rs.10 per share (at par)
- Payment terms: Entire issue price of Rs.10 per share payable on application
- Security type: Equity shares of Rs.10 each
- Settlement number: DR-806/2025-2026
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
- Trading members must ensure transactions in DR LALCHANDANI LABS LIMITED shares are conducted on ex-rights basis from January 27, 2026
- Trading members are required to take note of the record date and ex-rights date for proper settlement
Important Dates
- Notice Date: January 21, 2026
- Record Date: January 27, 2026
- Ex-Rights Date: January 27, 2026
- Settlement Number: DR-806/2025-2026
Impact Assessment
Market Impact: Medium - The 1:1 rights issue will potentially double the equity base of DR LALCHANDANI LABS LIMITED. Existing shareholders have the opportunity to maintain their proportional ownership by subscribing to the rights issue.
Shareholder Impact: Existing shareholders as of the record date (January 27, 2026) will be eligible to participate in the rights issue. The share price is expected to adjust for the ex-rights basis from January 27, 2026.
Liquidity Impact: Trading on ex-rights basis from January 27, 2026 may cause price adjustment to reflect the rights entitlement separation from the stock price.
Impact Justification
Standard rights issue announcement affecting existing shareholders of DR LALCHANDANI LABS LIMITED with 1:1 ratio at par value